Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0000919574-26-008200

Director bought 1,000,000 shares at $0.77 ($770,700)

From the SEC's structured data for this filing

Trades in this filing

BROADWOOD PARTNERS, L.P. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-17 Purchase : show line 1 in the form +1,000,000 $0.77 $770,700 50,560,992 D
2026-11-17 Purchase : show line 2 in the form +0 50,560,992 I
Open-market purchases · 1,000,000 sh · avg $0.77 · $770,700
Loading xslF345X06/ownership.xml…